Brief: Axcella Reports Q3 Loss Per Share $0.34

Axcella Health

12/11/2020 12:46

Nov 12 (Reuters) - Axcella Health Inc  AXLA.O :
    * AXCELLA REPORTS THIRD QUARTER 2020 FINANCIAL RESULTS AND
PROVIDES BUSINESS UPDATE
    * AXCELLA HEALTH INC - QTRLY LOSS PER SHARE $0.34
    * AXCELLA HEALTH INC -  PHASE 2B SERIAL BIOPSY CLINICAL
TRIAL
ENROLLING ADULT PATIENTS WITH NASH EXPECTED TO BE INITIATED IN
FIRST HALF OF 2021
    * AXCELLA HEALTH INC -  PHASE 2 CLINICAL TRIAL ENROLLING
SUBJECTS
WITH LIVER CIRRHOSIS EXPECTED TO BE INITIATED IN FIRST HALF OF
2021
    * AXCELLA HEALTH INC - EXPECTS TO COMMUNICATE DECISION
WHETHER TO
ENROLL ADDITIONAL SUBJECTS WITH SICKLE CELL DISEASE IN
AXA4010-001 STUDY BY EARLY 2021

Source text for Eikon:  ID:nBw7lDl13a 
Further company coverage:  AXLA.O 

 ((Reuters.Briefs@thomsonreuters.com;))